Target intelligence / Profile preview

RNA, U6 small nuclear 532, pseudogene (RNU6-532P)

Target
RNU6-532P
Molecular classification
Other (Pseudogene), Non-coding RNA, Small nuclear RNA (snRNA)-derived pseudogene
01

Overview

RNU6-532P is a pseudogene associated with the U6 small nuclear RNA family. The canonical U6 snRNA is a highly conserved and essential small nuclear RNA that plays a critical role in the spliceosome, the molecular complex responsible for removing introns from pre-mRNA during RNA splicing[5][7]. Pseudogenes such as RNU6-532P represent non-functional segments of DNA arising from duplication or retrotransposition events; they typically are not transcribed or translated into functional products. While some pseudogenes in other families can exhibit regulatory effects — such as acting as “miRNA decoys” or competitive endogenous RNAs (ceRNAs) — there is no evidence or documentation of RNU6-532P having such functions[4][1]. Pseudogenes are common in eukaryotic genomes and rarely participate directly in cellular processes. In summary, RNU6-532P is a non-functional pseudogene of the U6 snRNA family with no therapeutic, biomarker, or mechanistic relevance to human disease or pharmacology[1][5].

Other names
RNU6-532PU6 small nuclear RNA pseudogene 532
02

Mechanism of action

None. There are no mechanisms of action for drugs targeting this pseudogene.

03

Biological functions

None established for RNU6-532P specificallyGeneral functions of U6 snRNA pseudogenes may include regulatory roles such as competitive endogenous RNAs (ceRNAs) in rare cases, but are generally non-functional
04

Disease associations

Other (No established disease association for RNU6-532P)In a broader context, some pseudogenes can have regulatory roles in cancer, but this has not been documented for RNU6-532P specifically

Beyond the preview

Go deeper on RNA, U6 small nuclear 532, pseudogene (RNU6-532P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 532, pseudogene (RNU6-532P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call